Cargando…
Circulatory microRNAs as potential biomarkers for fatty liver disease: the Rotterdam study
BACKGROUND: Fatty liver disease (FLD) is the most common cause of liver dysfunction in developed countries. There is great interest in developing clinically valid and minimally invasive biomarkers to enhance early diagnosis of FLD. AIM: To investigate the potential of circulatory microRNAs (miRNAs)...
Autores principales: | Zhang, Xiaofang, Mens, Michelle M. J., Abozaid, Yasir J., Bos, Daniel, Darwish Murad, Sarwa, de Knegt, Robert J., Ikram, M. Arfan, Pan, Qiuwei, Ghanbari, Mohsen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7839694/ https://www.ncbi.nlm.nih.gov/pubmed/33244812 http://dx.doi.org/10.1111/apt.16177 |
Ejemplares similares
-
Circulatory MicroRNAs in Plasma and Atrial Fibrillation in the General Population: The Rotterdam Study
por: Geurts, Sven, et al.
Publicado: (2021) -
Plasma MicroRNA Signature of Alcohol Consumption: The Rotterdam Study
por: Karabegović, Irma, et al.
Publicado: (2022) -
TASL Practice Guidance on the Clinical Assessment and Management of Patients with Nonalcoholic Fatty Liver Disease
por: Yilmaz, Yusuf, et al.
Publicado: (2023) -
Migrant extractability: Centring the voices of egg providers in cross-border reproduction
por: Nahman, Michal
Publicado: (2018) -
Making mothers in jail: carceral reproduction of normative motherhood
por: Sufrin, Carolyn
Publicado: (2018)